Fig. 1From: A pilot randomized controlled trial of supervised, at-home, self-administered transcutaneous auricular vagus nerve stimulation (taVNS) to manage long COVID symptomsStudy Timeline and Overview. Participants were shipped a taVNS kit to self-administer in their homes. After receiving the kit, they received either two weeks of either active or sham taVNS. Subsequently, all participants received two additional weeks of active taVNS stimulationBack to article page